Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Kevin Mwangi

Profile

Projects

Publications & Research Data

Activities

Awards & Distinctions

Patents

2 Results

2025

Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy

Arne van der VrekenFabien Henri TheryChenggong TuKevin MwangiSofie MeulewaeterLien De BeckEdith JanssensKim De VeirmanKarin VanderkerkenElke De Bruyne et al.

A1 Journal Article in JOURNAL FOR IMMUNOTHERAPY OF CANCER

2025

Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs

Sofie MeulewaeterMargo De VelderDiethard ReckelbusKevin MwangiThomas EhouarneIlke AernoutYanou EngelenFëllanza HalimiIsis Van herteryckLobke De Bels et al.

A1 Journal Article in MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT

2025